Patents Assigned to Amplia Therapeutics Limited
  • Publication number: 20220340540
    Abstract: The present invention is directed to the tartrate salt of a FAK inhibitor defined by formula (I) below, and the use of that inhibitor for treating a proliferative disease.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 27, 2022
    Applicant: Amplia Therapeutics Limited
    Inventors: Christopher BURNS, John LAMBERT